Tyme Technologies, Inc.Company Review & Valuation
About Tyme Technologies, Inc.
Tyme Technologies, Inc., a clinical-stage biotechnology company, develops novel cancer therapeutics. It is developing SM-88, a combination therapy based on dysfunctional metyrosine derivatives in Phase II development for metastatic pancreatic cancer and biomarker-recurrent prostate cancer. The compa… Show moreny was founded in 2011 and is headquartered in New York, New York.Show less